Clovis Oncology clovisoncology.com


Public list: Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180)

Clovis Oncology is developing cancer treatments for certain patients who have metastatic pancreatic cancer, non-small cell lung cancer, and various solid tumors. The Company is focused on licensing or acquiring rights to oncology compounds in all stages of clinical development.

Clovis Oncology is developing cancer treatments for certain patients who have metastatic pancreatic cancer, non-small cell lung cancer, and various solid tumors. The Company is focused on licensing or acquiring rights to oncology compounds in all sta...Show all

Company (IPO / Went public)

Phone: 303-625-5000

Fax: 720-220-9122

5500 Flatiron Parkway

Boulder, 80301
Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Clovis Oncology $145M Aug 16, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Clovis Oncology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors

Competitors

Company Status Description Investors

Corthera

San Mateo, California, United States
AcquiredCorthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for the treatment of acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodil...Show allLogin to see details

QuatRx Pharmaceuticals

Ann Arbor, Michigan, United States
Alive / ActiveQuatRx Pharmaceuticals Company is focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. In addition to QRX-431, QuatRx currently has three product candidates in clinical development. QuatRxLogin to see details
See all 15 competitors